Keith Meister Amends WGS Form 4 to Report 2,806,925 Shares
Rhea-AI Filing Summary
Keith A. Meister, a director and reported 10% owner, amended a Form 4 to correct previously misstated holdings in GeneDx Holdings Corp. (WGS). The amendment clarifies that investment funds advised by Corvex Management LP hold 2,473,781 shares of Class A common stock and that CMLS Holdings LLC holds 333,144 shares, for an aggregate indirect beneficial ownership of 2,806,925 shares. The filing states Mr. Meister may be deemed to indirectly own these shares through his control or board role but disclaims direct beneficial ownership except for any pecuniary interest. The amendment notes the corrected figures reflect a 1-for-33 reverse stock split effective May 4, 2023.
Positive
- Amendment corrected the previously misstated share counts, improving disclosure accuracy
- Clear attribution of 2,806,925 shares indirectly beneficially owned, enhancing transparency
Negative
- Administrative error in the original Form 4 required correction
- Concentrated indirect stake (2,806,925 shares) may represent significant shareholder influence
Insights
TL;DR: An insider amendment corrects reported holdings to show material indirect ownership by an activist firm.
The corrected filing shows Corvex Management LP-advised funds hold 2,473,781 shares and CMLS Holdings LLC holds 333,144, totaling 2,806,925 Class A shares indirectly attributable to Mr. Meister. This clarifies the scale of an insider stake and the reporting chain through an investment adviser and a separate LLC.
The filing also includes a customary disclaimer of direct beneficial ownership and states the figures incorporate a May 4, 2023 1-for-33 reverse split. Investors should note the amendment corrects prior administrative errors; filings going forward are to be read with this correction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Investment funds advised by Corvex Management LP are the holders of 2,473,781 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. CMLS Holdings LLC ("CMLS Holdings") is the holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held by CMLS Holdings. For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.